s6y
Company name or ticker
Search
Apimeds Pharmaceuticals US, Inc.
3
Sherb Eric Michael: Initial statement of beneficial ownership of securities
Filed
Monday, November 2, 2026
Period
Dec 1, 2025
Accession number
0002090364-26-000001
Documents
PRIMARY DOCUMENT
3
On sec.gov
Filing index
All files
Complete submission text
SGML header